...
首页> 外文期刊>Future medicinal chemistry >Use of secondary structure element information in drug design: polypharmacology and conserved motifs in protein-ligand binding and protein-protein interfaces.
【24h】

Use of secondary structure element information in drug design: polypharmacology and conserved motifs in protein-ligand binding and protein-protein interfaces.

机译:二级结构元素信息在药物设计中的用途:蛋白质-配体结合和蛋白质-蛋白质界面中的多药理学和保守基序。

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

The structure-based design of small-molecule inhibitors of protein-ligand and protein-protein interfaces is a key component of drug discovery. The underlying protein interactions can be regarded based on structural similarity of the secondary structure elements: similarities around the binding site ('ligand-sensing cores') or in the protein interface ('interface-sensing surfaces') in otherwise unrelated proteins can be useful in predicting polypharmacology and identifying new lead structures. Even small conserved motifs can provide similar interaction patterns in proteins with a completely different fold and function. The identification of these structural similarities can help in the design of new drugs by guiding further optimization. Here, the concepts and ideas based on secondary structure element similarities and their successful applications in drug design are reviewed and discussed.
机译:蛋白质-配体和蛋白质-蛋白质界面的小分子抑制剂的基于结构的设计是药物发现的关键组成部分。可以基于二级结构元素的结构相似性来考虑潜在的蛋白质相互作用:否则,不相关的蛋白质在结合位点(“配体传感核心”)或蛋白质界面(“界面传感表面”)附近的相似性可能是有用的预测多元药理学和确定新的先导结构。即使是小的保守基序也可以在蛋白质中提供相似的相互作用模式,而折叠和功能却完全不同。这些结构相似性的鉴定可通过指导进一步优化来帮助设计新药。在此,对基于二级结构元素相似性的概念和思想及其在药物设计中的成功应用进行了回顾和讨论。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号